![](https://www.diabetesnews.com/wp-content/uploads/2013/10/n-PILL-large570-150x150.jpg)
An insulin pill, long desired by diabetes doctors and patients but abandoned as not physically viable, could be available by the end of this decade as a tiny Israeli company races a Danish pharmaceutical giant to be first with what could be a multibillion-dollar product.
Read more